Cite
HARVARD Citation
Goeree, R. et al. (2016). Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes. Journal of medical economics. pp. 630-644. [Online].